Page 11 - Ladyn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ladyn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ladyn Today - Breaking & Trending Today

Dyne Therapeutics (NASDAQ:DYN) Downgraded by StockNews.com to Sell

StockNews.com lowered shares of Dyne Therapeutics (NASDAQ:DYN – Get Rating) from a hold rating to a sell rating in a research report sent to investors on Friday. A number of other research firms also recently weighed in on DYN. Raymond James raised Dyne Therapeutics from an outperform rating to a strong-buy rating and upped their […] ....

United States , Raymond James , Raymond James Associates , Algert Global , Mirae Asset Global Investments Co , Financial Management Network Inc , International Biotechnology Trust , Dyne Therapeutics Inc , Dyne Therapeutics , Get Rating , Moderate Buy , Management Network , Biotechnology Trust , Mirae Asset Global Investments , Asset Global Investments , Dyne Therapeutics Daily , Nasdaq Dyn , Stocknews Com ,

Mondelez International, Inc. (NASDAQ:MDLZ) Shares Sold by RENASANT Bank

Monashee Investment Management LLC trimmed its holdings in Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Rating) by 38.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 123,719 shares of the company’s stock after selling 76,281 shares during the quarter. Monashee Investment Management LLC owned 0.24% […] ....

United States , Raymond James , Dyne Therapeutics Inc , Tower Research Capital , Exchange Commission , Group Plc , Monashee Investment Management , Dyne Therapeutics , Get Rating , Investment Management , General Group Plc , Research Capital , Strs Ohio , Therapeutics Stock Down , Dyne Therapeutics Daily , Nasdaq Dyn , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Dyne Therapeutics, Inc. (NASDAQ:DYN) Short Interest Up 14.0% in April

Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Rating) was the target of a large growth in short interest in April. As of April 15th, there was short interest totalling 4,880,000 shares, a growth of 14.0% from the March 31st total of 4,280,000 shares. Approximately 15.3% of the shares of the company are short sold. Based on […] ....

United States , Raymond James , Group Plc , Dyne Therapeutics Company Profile , Sphera Funds Management , Dyne Therapeutics Inc , Allspring Global Investments Holdings , Denali Advisors , Dyne Therapeutics , Get Rating , Global Investments Holdings , Funds Management , General Group Plc , Dyne Therapeutics Daily , Nasdaq Dyn ,

DekaBank Deutsche Girozentrale Buys Shares of 15,000 Dyne Therapeutics, Inc. (NASDAQ:DYN)

DekaBank Deutsche Girozentrale bought a new stake in shares of Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Rating) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 15,000 shares of the company’s stock, valued at approximately $171,000. Other large investors have also recently bought […] ....

United States , Raymond James , Dekabank Deutsche Girozentrale , Tower Research Capital , Dyne Therapeutics Company Profile , Denali Advisors , Group Plc , Dyne Therapeutics Inc , Dyne Therapeutics , Get Rating , General Group Plc , Research Capital , Visit Holdingschannel , Dyne Therapeutics Daily , Nasdaq Dyn , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Dyne Therapeutics (NASDAQ:DYN) Trading Up 3.9%

Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Rating) was up 3.9% during mid-day trading on Wednesday . The company traded as high as $10.19 and last traded at $10.11. Approximately 58,321 shares traded hands during trading, a decline of 82% from the average daily volume of 331,188 shares. The stock had previously closed at $9.73. Analyst […] ....

United States , Raymond James , Dyne Therapeutics Company Profile , Raymond James Associates , Dyne Therapeutics Inc , Allspring Global Investments Holdings , Dyne Therapeutics , Get Rating , Global Investments Holdings , Jane Street Group , Dyne Therapeutics Daily , Nasdaq Dyn ,